HEMERA BIOSCIENCES
Hemera Biosciences Inc. is a privately held biotechnology company founded in 2010. Our primary mission is to develop anti-complement gene based therapies for the treatment of dry and wet age related macular degeneration (AMD). AMD is the most common cause of blindness amongst the elderly with no treatment options currently available for 90% of patients that suffer from the dry form of the disease. Using our proprietary recombinant molecules, we have demonstrated a very significant reduction in complement mediated damage to ocular tissues in preclinical models of dry as well as wet AMD.
HEMERA BIOSCIENCES
Social Links:
Industry:
Biotechnology Genetics
Founded:
2010-01-01
Address:
Newton, Massachusetts, United States
Country:
United States
Website Url:
http://www.hemerabiosciences.com
Total Employee:
1+
Status:
Active
Contact:
617-784-3381
Email Addresses:
[email protected]
Total Funding:
1.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Apache Wordpress Plugins Microsoft Exchange Online Office 365 Mail
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
iECURE
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Founder
Official Site Inspections
http://www.hemerabiosciences.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Hemera Biosciences"
Hemera Biosciences - Crunchbase Company Profile & Funding
Organization. Hemera Biosciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email โฆSee details»
Hemera Biosciences LLC | LinkedIn
Hemera Biosciences LLC | 299 followers on LinkedIn. Developing HMR59, an intravitreal gene therapy, to preserve vision in eyes with dry age-related macular degeneration. | Hemera is a โฆSee details»
Hemera Biosciences, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Hemera Biosciences, Inc. of Waltham, MA. Get the latest business insights from Dun & Bradstreet.See details»
Hemera Biosciences Company Profile | Management and
[email protected]: Hemera Biosciences Top Competitors. Company Employees Revenue Top technologies; jCyte Inc. 9: $1.1 M: Solid Biosciences Inc. 15: $3.1 M: Vironexis. โฆSee details»
Hemera Biosciences - Craft
Hemera Biosciences is a company that uses gene therapy as a one-time treatment in patients with age-related macular degeneration (AMD). It develops HMR59, a drug that is injected in โฆSee details»
Hemera Biosciences LLC Overview | SignalHire Company Profile
Organization Website: hemerabiosciences.com : Social Links: Contact Email [email protected] Hemera Biosciences LLC industries Biotech: Headquarters Location: 800 South St, Waltham, โฆSee details»
Hemera Biosciences - PitchBook
Hemera Biosciences General Information Description. Developer of a gene therapy platform designed for the treatment of age-related macular degeneration. The company's platform โฆSee details»
Nextsource | Company Profile | Hemera Biosciences
Explore the company profile of Hemera Biosciences (hemerabiosciences.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Hemera Biosciences, Inc. (Hemera Biosciences, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธ โฆ
Bill Radvak, Co-founder and Executive Chairman of the Board, appointed interim Chief Executive Officer Dr. Adam Rogers, member of the Board of Directors, appointed interim President Paul โฆSee details»
Hemera Biosciences - Overview, News & Similar companies
View Hemera Biosciences (www.hemerabiosciences.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as โฆSee details»
Hemera Biosciences - Crunchbase Company Profile & Funding
Hemera Biosciences develops anti-complement gene-based therapies for the treatment of dry and wet age-related macular degeneration.See details»
Hemera Biosciences - Products, Competitors, Financials, โฆ
Dr. Rogers has published 27 articles in peer reviewed journals and co-authored two textbooks and numerous chapters in major ophthalmic textbooks. Since 2007 he has served on the board of โฆSee details»
Hemera Biosciences, Inc. - Drug pipelines, Patents, Clinical
Www.hemerabiosciences.com. Private Company | 2010 | Massachusetts, United States | < 10 | www.hemerabiosciences.com. Last update 23 Jan 2025. Overview. Pipeline. Deal. โฆSee details»
Hemera Biosciences Company Information - Funding, Investors, โฆ
Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»
Hemera Biosciences - Overview, Decision Makers & Competitors
Explore Hemera Biosciences at (hemerabiosciences.com) based in Newton, Massachusetts, United States. Discover its industry, revenue, and key employees. Find data for similar โฆSee details»
Hemera Biosciences - VentureRadar
Open PageRank: 7,427,105 | hemerabiosciences.com. VentureRadar Popularity. High. VentureRadar Popularity: High. The popularity score combines profile views, clicks and the โฆSee details»
Hemera Biosciences - CB Insights
Hemerabiosciences.com. Overview & Products; Financials; People; Executives 1. Hemera Biosciences Management Team1 Team Member. Hemera Biosciences has 1 executive. โฆSee details»
Hemera Biosciences - workinbiotech.com
Hemera Biosciences is developing gene therapies to treat age-related macular degeneration (AMD). As the biology driving AMD is better understood, more effective therapies can be โฆSee details»
J&J (JNJ) Acquires Rights for Hemera Biosciences' Gene Therapy
Dec 3, 2020 J&Jโs shares have risen 1.6% in the year so far compared with the industryโs 2.2% growth.. The acquisition expands Janssenโs eye disease portfolio, which was established in 2018.See details»
Janssen acquires rights to Hemeraโs eye-disorder gene therapy
Janssen Pharmaceuticals, a part of Johnson & Johnson, has acquired rights to investigational eye-disorder gene therapy called HMR59 from Hemera Biosciences for an undisclosed sum.See details»